Collegium Pharmaceutical
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.About COLL
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic.
COLL Key Statistics
Stock Snapshot
Collegium Pharmaceutical(COLL) stock is priced at $50.00, giving the company a market capitalization of 1.55B. It carries a P/E multiple of 30.32.
During the trading session on 2025-12-17, Collegium Pharmaceutical(COLL) shares reached a daily high of $50.00 and a low of $47.83. At a current price of $50.00, the stock is +4.5% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 354.57K, compared to an average daily volume of 497.51K.
Over the past 52 weeks, Collegium Pharmaceutical(COLL) stock has traded between a high of $50.00 and a low of $23.23.
Over the past 52 weeks, Collegium Pharmaceutical(COLL) stock has traded between a high of $50.00 and a low of $23.23.
COLL News
In the past quarter, Collegium Pharmaceutical reported a strong Q3, with revenue rising 31.4% year on year and topping analyst expectations by 10.7%, driven by...
Collegium Pharmaceutical earnings spark renewed investor attention Collegium Pharmaceutical (COLL) just turned heads with Q3 results, lifting revenue about 31%...